WednesdayNov 25, 2020 1:43 pm

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Unveils New, Timely Beverage – Unwined(TM)

Sharing Services Global (OTCQB: SHRG), a diversified holding company specializing in the health and wellness direct-selling industry, recently released a new beverage product that seems perfectly designed for 2020. Through its wholly owned subsidiary, Elevacity(R) U.S. LLC, SHRG’s new beverage, Unwined(TM), is formulated to promote relaxation, sleep and stress relief, while potentially helping with immune support. A recent article discussing this reads, “Unwined is a full-bodied, mood-enhancing drink made with a specific blend of antioxidants, adaptogens, extracts and minerals. This blend of ingredients is formulated to help reduce excess cortisol and promote relaxation and sleep. The tasty, berry-flavored wellness beverage…

Continue Reading

WednesdayNov 25, 2020 1:15 pm

QualityStocksNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) CEO Featured in TMX Group Video Interview Series

Canadian-based Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a company commercializing patented technology designed to advance existing rotating electric machines, on Tuesday announced that its chief executive officer Sue Ozdemir was featured in a newly released interview with TMX Group. During the interview, Ozdemir talks about the company’s history and current focus and commitment. The interview is part of TMX’s “The C-Suite at The Open” video interview series, which provides insight into how company executives think in the current business environment.  To view the full interview, visit https://ibn.fm/tr7nw To view the full press release, visit https://ibn.fm/zM8io About Exro Technologies Inc. Exro is a clean-tech…

Continue Reading

WednesdayNov 25, 2020 1:00 pm

As Global Cannabis Sales Grow 38% in 2020, Gage Cannabis Co. Expands to Offer Recreational Marijuana at Flagship Location

Research suggests cannabis sales increased 38% from 2019 to 2020 Gage expanding into fast-growing Michigan market, now offering recreational marijuana at flagship Ferndale location Adult-use cannabis revenues in Michigan projected at $1 billion per year for 2021, surpassing $1.5 billion by 2023 Quarterly sales nearly doubled to $11.9 million in Q2 2020 from $5.8 million in Q1, expected to surpass $13.1 million in Q3 Recent research published by BDSA (formerly BDS Analytics) suggests that the global cannabis industry continues to grow despite COVID-19, with forecasts predicting that 2020 sales will reach $19.7 billion - an increase of 38% from 2019 (https://ibn.fm/EkGXb).…

Continue Reading

WednesdayNov 25, 2020 12:30 pm

Rritual Superfoods’ Extensive Distribution Network Set to Take Functional Mushrooms Mainstream

Functional Mushrooms Market Set for CAGR of 5.6% Expected to Reach $24.85 billion by 2026 Rritual Superfoods Has Launched Three Mushroom-based Products Products Boost Immune System, Brain Power and Relieve Stress Company’s Extensive Distribution Network Set to Accelerate Sales Consumers today shop for food with a number of considerations in mind, including food safety and the health benefits of their selected grocery items. This has resulted in increased demand for functional foods, with one sector — functional mushrooms — projected to increase at a CAGR of 5.6% during 2021–2026. This would put the market for functional mushrooms at $24.85 billion…

Continue Reading

WednesdayNov 25, 2020 12:25 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Therapeutics Solution to Employees of Fortune 500 Company

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be providing its digital therapeutics solution to qualified employees of a U.S.-based Fortune 500 technology company. The contract, which goes into effect on Jan. 1, 2021, with the beginning of a new benefits year, calls for Dario to provide its digital diabetes tools and coaching to employees and their dependents. “We believe that employees will benefit from Dario's unique therapeutic approach, which delivers adaptive, personalized experiences designed to drive behavior change through intuitive, clinically proven digital tools and coaching,” said DarioHealth president and North America GM Rick Anderson…

Continue Reading

WednesdayNov 25, 2020 12:00 pm

Knightscope, Inc. Reimagines Public Safety Across the U.S. Through Autonomous Security Capabilities

Violent crimes in the U.S. occur every 24.6 seconds, and property crime occurs every 4.1 seconds There are over 320 million people in the U.S., with only two million+ law enforcement and security professionals to protect them Knightscope’s autonomous security robots are currently in operation across five U.S. time zones, with over one million hours in the field The K1 is an award-winning ASR whose achievements were recognized with the 2018 Security Today New Product of the Year Knightscope, a leader in the development of autonomous security capabilities, is reimagining public safety to make the United States the safest country…

Continue Reading

WednesdayNov 25, 2020 11:33 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Announces Executive Leadership Changes

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a chief financial officer, chief general counsel and senior vice president of investor and public communications. The company also plans to announce additional board members coming from key business and science segments. Current board members who are remaining include Dr. Roger McIntyre, chair and CEO; Bill Wilkerson, vice…

Continue Reading

WednesdayNov 25, 2020 11:30 am

Pure Extracts Technologies Corp. (CSE: PULL) Strengthens Oil Extraction Business, Ventures into Functional Mushroom Space

Pure Extracts carried out its initial oil extraction, distillation trials in early November, plans to commence extraction tolling services in December Once Sales License is obtained from Health Canada, the Company plans to begin marketing its own ‘Pure Pulls’ branded cannabis derived product range Pure Extracts will simultaneously seek to market Company’s white-labelling prowess, offering oil extraction capabilities to Licensed Producers currently operating in cannabis space Company also announced its interest in joining functional mushroom sector, with its first products set to be launched in 1Q2021 Separately, Pure Extracts named Dwight Duncan to its Board of Directors Pure Extracts Technologies…

Continue Reading

WednesdayNov 25, 2020 11:00 am

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Sells 15 Streamway(R) Systems in Q3 2020 as COVID-era Drives Need for Sanitation Systems

Closed design of Streamway(R) System provides safety from potential hazards of drips and spills during endoscopy, radiology, cystoscopy, urology procedures The Streamway(R) System reduces costs, minimizes environmental impact of 50 million potentially disease-infected canisters disposed into landfills POAI’s Skyline Medical sells 8 Streamway(R) Systems to large university hospital in Virginia, 15 sold halfway into Q3 2020 In the age of COVID-19, the need for sanitation and safety during hospital procedures has reached an all-time high. Health professionals have reported an inhibited level of performance due to a lack of protection, comfort, and increased fatigue during surgery (https://ibn.fm/87UEr). Sanitary disposal systems,…

Continue Reading

WednesdayNov 25, 2020 10:45 am

AzurRx BioPharma Inc. (NASDAQ: AZRX) Planning to Test Immediate Release MS1819 Capsules in Cystic Fibrosis Study

The company plans to add another study arm to its ongoing Phase 2b OPTION 2 clinical study which currently tests delayed release capsules If it receives FDA approval, AzurRx would be able to identify the optimal delivery method for its drug candidate MS1819 without significant extra costs or delays Enrollment in this arm of the study could begin as early as December 2020 AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, has submitted a protocol amendment request to the U.S. Food and Drug Administration that would allow it to test immediate…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered